Invited Commentary
Fibrinolysis Shutdown in COVID-19-Associated Coagulopathy: A Crosstalk among Immunity, Coagulation, and Specialists in Medicine and Surgery

https://doi.org/10.1016/j.jamcollsurg.2021.03.003Get rights and content

Cited by (0)

Disclosure Information: Nothing to disclose.

Disclosures outside the scope of this work: Dr Walsh receives lecture payments from Alexion Speakers Bureau. Dr Neal receives payment for board membership from Janssen Pharmaceuticals and CSL Behring, and receives research support from Janssen Pharmaceuticals, Haemonetics, Accriva, Diagnostics, Instrument Laboratories, and Noveome Therapeutics. Other authors have nothing to disclose.

Support: Dr Neal receives research support from NIH and the US Department of Defense.

View Abstract